Cite

HARVARD Citation

    Wang, X. et al. (2019). First-line checkpoint inhibitors for wild-type advanced non-small-cell cancer: a pair-wise and network meta-analysis. Immunotherapy. pp. 311-320. [Online]. 
  
Back to record